Taiwan FDA registration 89920a691efab891dec2e9e3e6c1b20e
FACILLE Rouge Light Facial Dermal Implant
TW: 法思麗柔姿輕感皮下填補劑
Taiwan·Risk Class 3·MD·SCIVISION BIOTECH INC.·Registered Dec 03, 2020 – Mar 01, 2026ExpiredRegistration details
- Analysis ID
- 89920a691efab891dec2e9e3e6c1b20e
- License Form
- Ministry of Health Medical Device Manufacturing No. 006939
Company information
- Manufacturer
- SCIVISION BIOTECH INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- SCIVISION BIOTECH INC.
Product details
- Intended Use
- Limited to the scope of identification of "hyaluronic acid implants (I.0007)" of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- I General and plastic surgical devices
- Product Type (Level 2)
- I0007 Hyaluronic acid implants
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Dec 03, 2020
- Expiry Date
- Mar 01, 2026
About this record
Access comprehensive regulatory information for FACILLE Rouge Light Facial Dermal Implant in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 89920a691efab891dec2e9e3e6c1b20e and manufactured by SCIVISION BIOTECH INC.. The authorized representative in Taiwan is SCIVISION BIOTECH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices